Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker IDXX
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2026 amended | Daniel M. Junius Director | IDXX IDEXX Laboratories, Inc. | 500 | $345.8K | — | Nov 4, 2026 | Form 4 ↗ same day · 1,200 shares | Form 144/A ↗ |
| Nov 5, 2026 amended | Daniel M. Junius Director | IDXX IDEXX Laboratories, Inc. | 700 | $494.0K | — | Nov 4, 2026 | Form 4 ↗ same day · 1,200 shares | Form 144/A ↗ |
| Nov 4, 2026 | Daniel M. Junius Director | IDXX IDEXX Laboratories, Inc. | 500 | $345.8K | — | Nov 4, 2026 | Form 4 ↗ 1 day later · 1,200 shares | Form 144 ↗ |
| Nov 4, 2026 | Jonathan J Mazelsky Officer, Director | IDXX IDEXX Laboratories, Inc. | 25,140 | $17.7M | — | Nov 4, 2026 | Form 4 ↗ 1 day later · 25,140 shares | Form 144 ↗ |
| Nov 4, 2026 | Sharon E Underberg Officer | IDXX IDEXX Laboratories, Inc. | 8,906 | $6.1M | — | Nov 4, 2026 | Form 4 ↗ 1 day later · 8,906 shares | Form 144 ↗ |
| Nov 4, 2026 | Michael J Lane Officer | IDXX IDEXX Laboratories, Inc. | 3,979 | $2.7M | — | Nov 4, 2026 | Form 4 ↗ 1 day later · 3,979 shares | Form 144 ↗ |
| Sep 4, 2026 | Lawrence D Kingsley Director | IDXX IDEXX Laboratories, Inc. | 2,203 | $1.2M | — | Sep 4, 2026 | Form 4 ↗ 5 days later · 2,203 shares | Form 144 ↗ |
| May 20, 2026 | Margaret Anne Szostak Director | IDXX IDEXX Laboratories, Inc. | 1,344 | $744.0K | — | May 20, 2026 | — | Form 144 ↗ |
| Mar 3, 2026 | Nimrata K Hunt Officer | IDXX IDEXX Laboratories, Inc. | 1,758 | $1.1M | — | Mar 3, 2026 | Form 4 ↗ 2 days later · 1,758 shares | Form 144 ↗ |
| Feb 26, 2026 | Jonathan J Mazelsky Officer, Director | IDXX IDEXX Laboratories, Inc. | 23,326 | $15.3M | — | Feb 26, 2026 | Form 4 ↗ 4 days later · 23,326 shares | Form 144 ↗ |
| Feb 25, 2026 | Nimrata K Hunt Officer | IDXX IDEXX Laboratories, Inc. | 2,693 | $1.8M | — | Feb 25, 2026 | Form 4 ↗ 2 days later · 2,693 shares | Form 144 ↗ |
| Feb 17, 2026 | Sophie V Vandebroek Director | IDXX IDEXX Laboratories, Inc. | 1,464 | $920.3K | — | Feb 17, 2026 | Form 4 ↗ 2 days later · 1,464 shares | Form 144 ↗ |
| Feb 17, 2026 | Michael G Erickson Officer | IDXX IDEXX Laboratories, Inc. | 5,371 | $3.4M | — | Feb 17, 2026 | Form 4 ↗ 2 days later · 5,371 shares | Form 144 ↗ |
| Feb 10, 2026 | George Fennell Officer | IDXX IDEXX Laboratories, Inc. | 11,345 | $7.3M | — | Feb 10, 2026 | Form 4 ↗ 1 day later · 11,345 shares | Form 144 ↗ |
| Nov 7, 2025 | Nimrata K Hunt Officer | IDXX IDEXX Laboratories, Inc. | 9,425 | $6.6M | — | Nov 7, 2025 | Form 4 ↗ 3 days later · 9,425 shares | Form 144 ↗ |
| Aug 22, 2025 | Margaret Anne Szostak Director | IDXX IDEXX Laboratories, Inc. | 2,187 | $1.4M | — | Aug 22, 2025 | Form 4 ↗ 4 days later · 2,187 shares | Form 144 ↗ |
| Aug 12, 2025 | Michael G Erickson Officer | IDXX IDEXX Laboratories, Inc. | 407 | $264.5K | — | Aug 12, 2025 | Form 4 ↗ 2 days later · 406 shares | Form 144 ↗ |
| Aug 11, 2025 | Nimrata K Hunt Officer | IDXX IDEXX Laboratories, Inc. | 1,200 | $787.8K | — | Aug 11, 2025 | Form 4 ↗ 2 days later · 1,200 shares | Form 144 ↗ |
| Aug 8, 2025 | Sharon E Underberg Officer | IDXX IDEXX Laboratories, Inc. | 5,450 | $3.6M | — | Aug 8, 2025 | Form 4 ↗ 4 days later · 5,450 shares | Form 144 ↗ |
| Aug 6, 2025 | Nimrata K Hunt Officer | IDXX IDEXX Laboratories, Inc. | 7,143 | $4.5M | — | Aug 6, 2025 | Form 4 ↗ 2 days later · 7,143 shares | Form 144 ↗ |
| Aug 6, 2025 | Jonathan J Mazelsky Officer, Director | IDXX IDEXX Laboratories, Inc. | 29,260 | $18.5M | — | Aug 6, 2025 | Form 4 ↗ 2 days later · 29,260 shares | Form 144 ↗ |
| Aug 6, 2025 | Michael J Lane Officer | IDXX IDEXX Laboratories, Inc. | 8,411 | $5.3M | — | Aug 6, 2025 | Form 4 ↗ 2 days later · 8,411 shares | Form 144 ↗ |
| May 21, 2025 | Szostak M Anne Director | IDXX IDEXX Laboratories, Inc. | 1,046 | $540.9K | — | May 21, 2025 | Form 4 ↗ 2 days later · 2,306 shares | Form 144 ↗ |
| May 21, 2025 | Szostak M Anne Director | IDXX IDEXX Laboratories, Inc. | 1,260 | $651.6K | — | May 21, 2025 | Form 4 ↗ 2 days later · 2,306 shares | Form 144 ↗ |
| May 13, 2025 | Daniel M. Junius Director | IDXX IDEXX Laboratories, Inc. | 2,683 | $1.4M | — | May 13, 2025 | Form 4 ↗ 1 day later · 2,683 shares | Form 144 ↗ |
| May 9, 2025 | Sophie V. Vandebroek Director | IDXX IDEXX Laboratories, Inc. | 1,279 | $628.4K | — | May 9, 2025 | Form 4 ↗ 4 days later · 1,279 shares | Form 144 ↗ |
| May 2, 2025 | COLLINS Asha Director | IDXX IDEXX Laboratories, Inc. | 2,671 | $1.3M | — | May 2, 2025 | — | Form 144 ↗ |
| Feb 10, 2025 | George Fennell Officer | IDXX IDEXX Laboratories, Inc. | 9,966 | $4.6M | — | Feb 10, 2025 | Form 4 ↗ 1 day later · 9,986 shares | Form 144 ↗ |
| Feb 7, 2025 | Margaret Anne Szostak Director | IDXX IDEXX Laboratories, Inc. | 3,000 | $1.4M | — | Feb 7, 2025 | Form 4 ↗ 3 days later · 3,000 shares | Form 144 ↗ |
| Nov 27, 2024 | Sophie V. Vandebroek Director | IDXX IDEXX Laboratories, Inc. | 344 | $144.6K | — | Nov 27, 2024 | Form 4 ↗ 2 days later · 344 shares | Form 144 ↗ |
| Sep 6, 2024 | M. Anne Szostak Director | IDXX IDEXX Laboratories, Inc. | 500 | $234.9K | — | Sep 6, 2024 | — | Form 144 ↗ |
| May 17, 2024 | Bruce L. Claflin Director | IDXX IDEXX Laboratories, Inc. | 200 | $108.2K | — | May 17, 2024 | — | Form 144 ↗ |
| Mar 6, 2024 | James F. Polewaczyk Officer | IDXX IDEXX Laboratories, Inc. | 8,104 | $4.7M | — | Mar 6, 2024 | — | Form 144 ↗ |
| Mar 5, 2024 | Sophie V. Vandebroek Director | IDXX IDEXX Laboratories, Inc. | 1,404 | $790.4K | — | Mar 5, 2024 | — | Form 144 ↗ |
| Feb 8, 2024 | George Fennell Officer | IDXX IDEXX Laboratories, Inc. | 8,198 | $4.3M | — | Feb 8, 2024 | — | Form 144 ↗ |
| Feb 7, 2024 | Jonathan Jay Mazelsky Officer | IDXX IDEXX Laboratories, Inc. | 12,000 | $6.2M | — | Feb 7, 2024 | — | Form 144 ↗ |
| Feb 7, 2024 | Brian P. McKeon Officer | IDXX IDEXX Laboratories, Inc. | 23,326 | $12.0M | — | Feb 7, 2024 | — | Form 144 ↗ |
| Dec 7, 2023 | James F. Polewaczyk Officer | IDXX IDEXX Laboratories, Inc. | 11,636 | $5.6M | — | Dec 7, 2023 | — | Form 144 ↗ |
| Dec 4, 2023 | Jonathan Jay Mazelsky Officer | IDXX IDEXX Laboratories, Inc. | 7,128 | $3.4M | — | Dec 4, 2023 | — | Form 144 ↗ |
| Aug 31, 2023 | Jonathan Jay Mazelsky Officer | IDXX IDEXX Laboratories, Inc. | 13,424 | $6.9M | — | Aug 31, 2023 | — | Form 144 ↗ |
| Aug 29, 2023 | James F. Polewaczyk Officer | IDXX IDEXX Laboratories, Inc. | 22,909 | $11.6M | — | Aug 29, 2023 | — | Form 144 ↗ |
| Aug 3, 2023 | Lane Michael Officer | IDXX IDEXX Laboratories, Inc. | 16,027 | $8.2M | — | Aug 3, 2023 | — | Form 144 ↗ |
| May 19, 2023 | Jonathan W. Ayers Director | IDXX IDEXX Laboratories, Inc. | 10,000 | $4.9M | — | May 19, 2023 | — | Form 144 ↗ |
| May 18, 2023 | Jonathan W. Ayers Director | IDXX IDEXX Laboratories, Inc. | 10,000 | $4.9M | — | May 18, 2023 | — | Form 144 ↗ |
| May 16, 2023 | Kathy V. Turner Officer | IDXX IDEXX Laboratories, Inc. | 2,510 | $1.2M | — | May 16, 2023 | — | Form 144 ↗ |
| May 10, 2023 | Kathy V. Turner Officer | IDXX IDEXX Laboratories, Inc. | 4,270 | $2.1M | — | May 10, 2023 | — | Form 144 ↗ |
| May 5, 2023 | Lane Michael Officer | IDXX IDEXX Laboratories, Inc. | 1,000 | $484.0K | — | May 5, 2023 | — | Form 144 ↗ |
| May 5, 2023 | Margaret Anne Szostak Director | IDXX IDEXX Laboratories, Inc. | 2,000 | $957.7K | — | May 5, 2023 | — | Form 144 ↗ |
| May 4, 2023 | Sophie V. Vandebroek Officer | IDXX IDEXX Laboratories, Inc. | 2,187 | $1.0M | — | May 4, 2023 | — | Form 144 ↗ |
49 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:28 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances